Ferris Capital’s Corbus Pharmaceuticals CRBP Stock Holding History

Ferris Capital’s Portfolio CRBP Stock Details CRBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-1	Closed	–	–	688
2018 Q1	$0	Buy	+1	New	+$225	﹤0.01%	700

Other funds holding CRBP

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Ferris Capital's CRBP Position: Q2 2018 in Review

Ferris Capital sold out of Corbus Pharmaceuticals (CRBP) in Q2 2018, closing a stake of 1 share.

Ferris Capital first reported a position in CRBP in Q1 2018 and held it in 1 quarter. The position peaked at $0 in Q1 2018. 82 funds tracked by Wall St. Rank hold CRBP as of Q2 2018.

Ferris Capital reported no remaining Corbus Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
Ferris Capital sold 1 Corbus Pharmaceuticals share in Q2 2018.
Ferris Capital first reported a position in Corbus Pharmaceuticals in Q1 2018 and held it in 1 quarter.
Ferris Capital's Corbus Pharmaceuticals position peaked at $0 in Q1 2018.
82 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2018.

Based on Ferris Capital's 13F filing for Q2 2018, filed 10 Aug 2018.